Synthetic control arms
A top 20 pharma company is designing a clinical trial for a new rare disease drug. Its goal is to accelerate treatments going to market and increase efficiency in clinical trial design. The company must have a comparator to present to the FDA.
Discover how the pharma company was able to:
- License interoperable real-world data
- Incorporate patient data into the clinical trial analysis plan
- Build out a real-world control group to demonstrate the safety and efficacy to FDA